Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.

Clinical trial NCT03055026 · COMPLETED

Trial details

NCT number: NCT03055026
Sponsor: Fadoi Foundation, Italy
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prevention of Venous Thromboembolism

Start date: 2017-05-03
Primary completion: 2021-07-09
Enrollment: 582

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.